Ruiz-Pablos, Manuel, Paiva, Bruno, Zabaleta, Aintzane · Frontiers in immunology · 2024 · DOI
This review proposes that ME/CFS, long COVID, and post-vaccine syndrome may share a common cause: an immune system problem that damages the pituitary gland (a small gland that controls many hormones). The researchers suggest that in genetically susceptible people, a weak initial response to viruses can lead to an overactive immune response that mistakenly attacks the body's own pituitary gland, lowering levels of crucial hormones like cortisol. They propose that treatments like antivirals, steroids, and antioxidants might help by reducing inflammation and restoring hormone balance.
This work attempts to unify ME/CFS with long COVID and post-vaccine conditions under a single immunological framework, which could guide future treatment strategies and research priorities. If the pituitary-immune connection is confirmed, it could open new diagnostic and therapeutic avenues for patients with these debilitating conditions. Understanding shared mechanisms may accelerate development of targeted interventions for all three patient populations.
This is a narrative review, not a primary research study, so it presents proposed mechanisms rather than new experimental or clinical evidence. The study does not prove that pituitary autoimmunity is the primary cause of these conditions—it is a theoretical model based on literature integration. It also does not establish that the proposed treatments (antivirals, corticosteroids, antioxidants) are effective in ME/CFS or long COVID, as no clinical trial data are presented.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →